Hua Wu

4.5k total citations · 2 hit papers
104 papers, 3.4k citations indexed

About

Hua Wu is a scholar working on Radiology, Nuclear Medicine and Imaging, Surgery and Oncology. According to data from OpenAlex, Hua Wu has authored 104 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Radiology, Nuclear Medicine and Imaging, 39 papers in Surgery and 37 papers in Oncology. Recurrent topics in Hua Wu's work include Peptidase Inhibition and Analysis (29 papers), Radiopharmaceutical Chemistry and Applications (22 papers) and Medical Imaging Techniques and Applications (18 papers). Hua Wu is often cited by papers focused on Peptidase Inhibition and Analysis (29 papers), Radiopharmaceutical Chemistry and Applications (22 papers) and Medical Imaging Techniques and Applications (18 papers). Hua Wu collaborates with scholars based in China, Canada and Singapore. Hua Wu's co-authors include Haojun Chen, Long Sun, Yizhen Pang, Qin Lin, Liang Zhao, Ying Wan, Bing Hao, Zuoming Luo, Xiaoying Cao and Long Zhao and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Hua Wu

102 papers receiving 3.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer

2020 398 citations Haojun Chen, Yizhen Pang et al. European Journal of Nuclear Medicine and Molecular Imaging profile →
Fibroblast activation protein-based theranostics in cancer research: A state-of-the-art review

2022 128 citations Liang Zhao, Jianhao Chen et al. Theranostics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hua Wu China	32	1.9k	1.2k	1.0k	944	493	104	3.4k
Alain Chapel France	28	715 0.4×	1.0k 0.9×	302 0.3×	725 0.8×	262 0.5×	67	3.6k
Yuichi Ozeki Japan	30	911 0.5×	582 0.5×	466 0.4×	378 0.4×	337 0.7×	110	3.5k
Akihiko Matsumine Japan	36	1.5k 0.8×	794 0.7×	414 0.4×	180 0.2×	106 0.2×	225	5.0k
Masanobu Shindoh Japan	43	1.6k 0.9×	441 0.4×	1.5k 1.5×	156 0.2×	171 0.3×	165	5.3k
Sean P. Scully United States	43	1.2k 0.6×	1.7k 1.4×	1.2k 1.2×	426 0.5×	117 0.2×	124	6.2k
Hideo Morioka Japan	35	1.2k 0.7×	802 0.7×	572 0.5×	81 0.1×	263 0.5×	160	4.7k
Yamato Kikkawa Japan	30	374 0.2×	375 0.3×	358 0.3×	198 0.2×	347 0.7×	104	3.5k
Olivia Fromigué France	32	926 0.5×	394 0.3×	467 0.4×	206 0.2×	144 0.3×	60	3.0k
Jianhua Wang China	22	699 0.4×	494 0.4×	213 0.2×	271 0.3×	214 0.4×	106	2.9k
Anja Seckinger Germany	33	984 0.5×	851 0.7×	348 0.3×	122 0.1×	348 0.7×	115	4.2k

Countries citing papers authored by Hua Wu

Since Specialization

Citations

This map shows the geographic impact of Hua Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hua Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hua Wu more than expected).

Fields of papers citing papers by Hua Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hua Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hua Wu. The network helps show where Hua Wu may publish in the future.

Co-authorship network of co-authors of Hua Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Hua Wu. A scholar is included among the top collaborators of Hua Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hua Wu. Hua Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Liang, Yizhen Pang, Daqiang Xu, et al.. (2025). Preclinical and pilot clinical evaluation of novel dual-modality pet/fluorescence probes targeting FAP for accurate tumor margin delineation. European Journal of Nuclear Medicine and Molecular Imaging. 53(3). 1479–1490.

Fu, Hao, Liang Zhao, Weizhi Xu, et al.. (2025). 177Lu-LNC1004 Radioligand Therapy in Patients with End-stage Metastatic Cancers: A Single-Center, Single-Arm, Phase II Study. Clinical Cancer Research. 31(8). 1415–1426. 13 indexed citations

Zhao, Liang, Yizhen Pang, Yi Ding, et al.. (2025). 68Ga-NK224 PET/CT for Noninvasive Evaluation of PD-L1 Expression and Intertumor Heterogeneity: A Translational Exploratory Study. Clinical Cancer Research. 31(14). 2989–3001. 3 indexed citations

Fang, Yiqi, et al.. (2024). Electrospun high hydrophilicity antimicrobial poly (lactic acid)/silk fibroin nanofiber membrane for wound dressings. International Journal of Biological Macromolecules. 277(Pt 1). 133905–133905. 17 indexed citations

Zhao, Liang, Fei Kang, Yizhen Pang, et al.. (2024). Fibroblast Activation Protein Inhibitor Tracers and Their Preclinical, Translational, and Clinical Status in China. Journal of Nuclear Medicine. 65(Supplement 1). 4S–11S. 16 indexed citations

Fu, Hao, Tianzhi Zhao, Hongjian Wang, et al.. (2023). Fibroblast Activation Protein-Targeted Radioligand Therapy with 177Lu-EB-FAPI for Metastatic Radioiodine-Refractory Thyroid Cancer: First-in-Human, Dose-Escalation Study. Clinical Cancer Research. 29(23). 4740–4750. 56 indexed citations

Han, Haiwei, et al.. (2023). Persistent neuroinflammation of the right insular cortex in children with juvenile idiopathic arthritis: a proton MRS study. Clinical Rheumatology. 42(11). 3059–3066. 1 indexed citations

Pang, Yizhen, Liang Zhao, Tinghua Meng, et al.. (2022). PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using⁶⁸Ga-FAP-2286: Comparison with¹⁸F-FDG and⁶⁸Ga-FAPI-46 in a Single-Center, Prospective Study. Journal of Nuclear Medicine. 64(3). 386–394. 71 indexed citations

Zhao, Liang, Jianhao Chen, Yizhen Pang, et al.. (2022). Fibroblast activation protein-based theranostics in cancer research: A state-of-the-art review. Theranostics. 12(4). 1557–1569. 128 indexed citations breakdown →

10.

Zhao, Liang, Haojun Chen, Zhide Guo, et al.. (2020). Targeted Radionuclide Therapy in Patient-Derived Xenografts Using 177Lu-EB-RGD. Molecular Cancer Therapeutics. 19(10). 2034–2043. 24 indexed citations

11.

Pang, Yizhen, Liang Zhao, Zuoming Luo, et al.. (2020). Comparison of ⁶⁸Ga-FAPI and ¹⁸F-FDG Uptake in Gastric, Duodenal, and Colorectal Cancers. Radiology. 298(2). 393–402. 197 indexed citations

12.

Guo, Wei, Yizhen Pang, Liang Zhao, et al.. (2020). Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [68Ga]Ga-FAPI-04 PET/CT versus MRI and [18F]-FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 48(5). 1604–1617. 123 indexed citations

13.

Yi, Zhiqian, Yixi Su, David R. Nelson, et al.. (2019). Combined artificial high-silicate medium and LED illumination promote carotenoid accumulation in the marine diatom Phaeodactylum tricornutum. Microbial Cell Factories. 18(1). 209–209. 37 indexed citations

14.

Fu, Hao, et al.. (2018). 18F-FDG PET/CT imaging on a case of desmoplastic small round cell tumor in spermatic cord. 38(10). 695–696.

15.

Dou, Xiaofeng, Jianghua Yan, Yafei Zhang, et al.. (2016). SPECT imaging of neuropilin receptor type-1 expression with 131I-labeled monoclonal antibody. International Journal of Oncology. 49(3). 961–970. 6 indexed citations

16.

Sun, Long, Maoqing Jiang, Long Zhao, Zuoming Luo, & Hua Wu. (2013). Clinical application of 18F-FDG PET/CT for cardiac neoplasm diagnosis. 33(3). 175–178. 1 indexed citations

17.

Zhou, Nuo, Xiaoli Zan, Zheng Wang, et al.. (2013). Galactosylated chitosan–polycaprolactone nanoparticles for hepatocyte-targeted delivery of curcumin. Carbohydrate Polymers. 94(1). 420–429. 73 indexed citations

18.

Lin, Qin, et al.. (2012). The value of 18F-FDG PET/CT in N staging nasopharyngeal carcinoma patients. 32(6). 418–421. 1 indexed citations

19.

Lin, Qin, et al.. (2012). Comparative study of gross tumor volume shown on MRI and FDG PET/CT of nasopharyngeal carcinoma. Zhonghua fangshe zhongliuxue zazhi. 21(6). 492–495. 1 indexed citations

20.

Wu, Hua, Antonia Dimitrakopoulou‐Strauss, Burkhard Lehner, et al.. (2001). Quantitative evaluation of skeletal tumours with dynamic FDG PET: SUV in comparison to Patlak analysis. European Journal of Nuclear Medicine and Molecular Imaging. 28(6). 704–710. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact